The C-terminus of murine S100A9 inhibits hyperalgesia and edema induced by jararhagin

被引：26
|
作者：
Dale, CS
Gonçalves, LRC
Juliano, L
Juliano, MA
da Silva, AMM
Giorgi, R
机构：
[1] Butantan Inst, Lab Pathophysiol, BR-05503900 Sao Paulo, Brazil
[2] Univ Fed Sao Paulo, Inst Pharmacol, Dept Biophys, BR-04044020 Sao Paulo, Brazil
[3] Butantan Inst, Immunopathol Lab, BR-05503900 Sao Paulo, Brazil
来源：
PEPTIDES | 2004年 / 25卷 / 01期
基金：
巴西圣保罗研究基金会;
关键词：
hyperalgesia; edema; jararhagin; papain; MRP-14; S100A9;
D O I：
10.1016/j.peptides.2003.12.008
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The effect of a synthetic peptide (H-92-G(110)) identical to the C-terminus of murine S100A9 (mS100A9p) was investigated on hyperalgesia and edema induced by either jararhagin or papain in the rat paw. mS100A9p not only reverted hyperalgesia and edema induced by jararhagin, but also the highest concentration induced antinociception. Hemorrhage induced by jararhagin and its hydrolytic activity were inhibited by mS100A9p. These data suggest that mS100A9p might block jararhagin-induced hyperalgesia and edema by inhibiting jararhagin catalytic activity, since papain-induced hyperalgesia and edema were not inhibited by mS100A9p. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码：81 / 89
页数：9
相关论文
共 50 条
  • [1] The C-terminus of murine S100A9 inhibits spreading and phagocytic activity of adherent peritoneal cells
    R. L. Pagano
    S. C. Sampaio
    L. Juliano
    M. A. Juliano
    R. Giorgi
    Inflammation Research, 2005, 54 : 204 - 210
  • [2] The C-terminus of murine S100A9 inhibits spreading and phagocytic activity of adherent peritoneal cells
    Pagano, RL
    Sampaio, SC
    Juliano, L
    Juliano, MA
    Giorgi, R
    INFLAMMATION RESEARCH, 2005, 54 (05) : 204 - 210
  • [3] The C-terminus of murine S100A9 protein inhibits hyperalgesia induced by the agonist peptide of protease-activated receptor 2 (PAR2)
    Dale, C. S.
    Cenac, N.
    Britto, L. R. G.
    Juliano, M. A.
    Juliano, L.
    Vergnolle, N.
    Giorgi, R.
    BRITISH JOURNAL OF PHARMACOLOGY, 2006, 149 (04) : 374 - 384
  • [4] Effect of the C-terminus of murine S100A9 protein on experimental nociception
    Dale, Camila Squarzoni
    Pagano, Rosana de Lima
    Paccola, Carina Cicconi
    Pinotti-Guirao, Tatiana
    Juliano, Maria Aparecida
    Juliano, Luiz
    Giorgi, Renata
    PEPTIDES, 2006, 27 (11) : 2794 - 2802
  • [5] Antinociceptive effect of the C-terminus of murine S100A9 protein on experimental neuropathic pain
    Paccola, Carina Cicconi
    Gutierrez, Vanessa Pacciari
    Longo, Ingrid
    Juliano, Luiz
    Juliano, Maria Aparecida
    Giorgi, Renata
    PEPTIDES, 2008, 29 (10) : 1806 - 1814
  • [6] Inhibition of Macrophage Functions by the C-Terminus of Murine S100A9 Is Dependent on B-1 Cells
    Pagano, Rosana Lima
    Moraes, Natassja Foizer
    De Lorenzo, Beatriz Helena
    Sampaio, Sandra Coccuzzo
    Mariano, Mario
    Giorgi, Renata
    MEDIATORS OF INFLAMMATION, 2014, 2014
  • [7] Synthetic peptide identical to the C-terminus of the murine S100A9 (MRP-14) protein inhibits the function of adherent peritoneal cells
    Pagano, R. L.
    Sampaio, S. C.
    Juliano, L.
    Juliano, M. A.
    Giorgi, R.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 93 - 93
  • [8] Inhibitory effect of synthetic peptide to the C-terminus of the murine S100A9 protein on phagocytosis of adherent peritoneal cells stimulated with either thrombin
    Pagano, R.
    Sampaio, S. C.
    Juliano, L.
    Juliano, M. A.
    Giorgi, R.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 93 - 93
  • [9] Comparative evaluation of the antinociceptive effects of different peptide sequences that are homologous to the C-terminus of murine S100A9 protein (MRP-14)
    Dale, C. S.
    Pagano, R. L.
    Juliano, L.
    Juliano, M. A.
    Giorgi, R.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 94 - 94
  • [10] Activity of a peptide identical to C-terminus region of the murine and human S100A9 protein (MRP-14) on in vivo neutrophilic migration
    Seixas, A. L. C.
    Pagano, R. L.
    Juliano, L.
    Juliano, M. A.
    Giorgi, R.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 94 - 94
12345